Novo’s older obesity drug is safe and effective for children, study finds
- Children using the weight loss drug Liraglutide lost significantly more weight than those receiving a placebo in a late-stage trial, according to a new study.
- The first study of Liraglutide's effects on younger children showed it could significantly impact their body mass index .
- Liraglutide was deemed safe for young children; however, some adverse stomach problems were reported in both groups during the study.
Insights by Ground AI
Does this summary seem wrong?
Coverage Details
Total News Sources0
Leaning Left10Leaning Right4Center15Last UpdatedBias Distribution52% Center
Bias Distribution
- 52% of the sources are Center
51% Center
L 35%
C 51%
14%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
